SLC9A3 and heart failure: NHE3 inhibitors have specific effects on hypertensive and heart failure patients and, particularly, in patients with heart failure where the diuretic treatment becomes progressively ineffective or patients develop diuretic resistance and/or concurrent renal failure and hypokalaemia [92].